Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 1/20 | 0.63 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | ACHE | P22303 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL609198 | 0.98 | ALDH1A1 (0.64) | TRIM24TRIM33ALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL817331 | 0.98 | ALDH1A1 (0.64) | TRIM24TRIM33ALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL628551 | 0.93 | ALDH1A1 (0.58) | TRIM24TRIM33ALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL2904812 | 0.83 | ALDH1A1 (0.54) | ALDH1A1SMN1; SMN2KDM4EMAPTMEN1 | |
| SCHEMBL99032 | 0.83 | ALDH1A1 (0.69) | ALDH1A1SMN1; SMN2KDM4EMAPTMEN1 | |
| SCHEMBL13766546 | 0.81 | TRIM24 (0.68) | TRIM24TRIM33ALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL14394962 | 0.81 | ADRB1 (0.57) | ALDH1A1KDM4EUSP2HSD17B10 | |
| SCHEMBL2174173 | 0.80 | ALDH1A1 (0.67) | TRIM24TRIM33ALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL7718270 | 0.79 | ALDH1A1 (0.69) | TRIM24TRIM33ALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL7718267 | 0.79 | ALDH1A1 (0.69) | TRIM24TRIM33ALDH1A1SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3950724-B1 | CONJUGATED DIENE COPOLYMER AND METHOD FOR MANUFACTURING CONJUGATED DIENE COPOLYMER | ZEON CORP (JP) | 2026-02-18 | — | — | EP | disclosed |
| CN-119462553-A | Development of novel red light and deep red light emission nile red derivative and application of novel red light and deep red light emission nile red derivative in cell lipid drop fluorescence imaging | 吉林大学 | 2025-02-18 | — | — | CN | disclosed |
| EP-3604365-B1 | CONJUGATED DIENE POLYMER AND METHOD FOR PRODUCING CONJUGATED DIENE POLYMER | SUMITOMO CHEMICAL CO (JP) | 2024-04-24 | — | — | EP | disclosed |
| CN-113748134-B | Conjugated diene copolymer and method for producing conjugated diene copolymer | 瑞住合成橡胶株式会社 | 2024-03-08 | — | — | CN | disclosed |
| CN-110461893-B | Conjugated diene polymer and method for producing conjugated diene polymer | 住友化学株式会社 | 2023-10-27 | — | — | CN | disclosed |
| US-20220396583-A1 | COMPOUNDS AS MODULATORS OF TLR2 SIGNALING | NEUROPORE THERAPIES, INC. (US) | 2022-12-15 | — | — | US | disclosed |
| US-11377513-B2 | Conjugated diene polymer and method for producing conjugated diene polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-07-05 | — | — | US | disclosed |
| US-11345713-B2 | Compounds as modulators of TLR2 signaling | NEUROPORE THERAPIES, INC. (US) | 2022-05-31 | — | — | US | disclosed |
| EP-3950724-A1 | CONJUGATED DIENE COPOLYMER AND METHOD FOR MANUFACTURING CONJUGATED DIENE COPOLYMER | ZS Elastomers Co., Ltd. (JP) | 2022-02-09 | — | — | EP | disclosed |
| EP-3774736-A1 | COMPOUNDS AS MODULATORS OF TLR2 SIGNALING | Neuropore Therapies, Inc. (US) | 2021-02-17 | — | — | EP | disclosed |
| US-20120041134-A1 | CONJUGATED DIENE-BASED POLYMER, CONJUGATED DIENE-BASED POLYMER COMPOSITION, AND PROCESS FOR PRODUCING CONJUGATED DIENE-BASED POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-16 | — | — | US | disclosed |
| US-20120041135-A1 | CONJUGATED DIENE-BASED POLYMER, CONJUGATED DIENE-BASED POLYMER COMPOSITION, AND PROCESS FOR PRODUCING CONJUGATED DIENE-BASED POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-16 | — | — | US | disclosed |
| CN-102286130-A | Conjugated diene polymer, conjugated diene polymer composition, and method for producing conjugated diene polymer | — | 2011-12-21 | — | — | CN | disclosed |
| US-20110275756-A1 | CONJUGATED DIENE POLYMER, CONJUGATED DIENE POLYMER COMPOSITION, AND METHOD FOR PRODUCING CONJUGATED DIENE POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-11-10 | — | — | US | disclosed |
| US-20110245398-A1 | METHOD FOR PRODUCING CONJUGATED DIENE POLYMER COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-10-06 | — | — | US | disclosed |
| CN-102206353-A | Method for producing conjugated diene polymer composition | SUMITOMO CHEMICAL CO | 2011-10-05 | — | — | CN | disclosed |
| US-20070078120-A1 | Novel piperidine derivative | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2007-04-05 | — | — | US | disclosed |
| US-4770973-A | READABLE BY OPTICAL DEVICES AND FIXED BY LIGHT | Kanzaki Paper Manufacturing Limited (JP) | 1988-09-13 | — | — | US | disclosed |
| EP-0242169-A2 | Divinyl compounds and chromogenic recording material prepared by use thereof | YAMADA CHEMICAL CO., LTD. (JP) | 1987-10-21 | — | — | EP | disclosed |
| EP-0127203-A1 | New phthalide derivatives, process for preparing the same and recording system utilizing the same as colourless chromogenic material | KANZAKI PAPER MANUFACTURING CO., LTD (JP) | 1984-12-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070078120-A1 | Novel piperidine derivative | LDLR, PRMT5, MSR1 | TRIM24 2438/4885TRIM33 3871/4885ALDH1A1 2990/4885 |
| US-11345713-B2 | Compounds as modulators of TLR2 signaling | TLR2, TLR4, TLR3 | TRIM24 1887/4885TRIM33 3127/4885ALDH1A1 4464/4885 |
| US-20220396583-A1 | COMPOUNDS AS MODULATORS OF TLR2 SIGNALING | TLR2, TLR4, TLR3 | TRIM24 1887/4885TRIM33 3127/4885ALDH1A1 4464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.